Lori Lyons-Williams - Apr 4, 2024 Form 3 Insider Report for Contineum Therapeutics, Inc. (CTNM)

Role
Director
Signature
/s/ Peter Slover, Attorney-in-Fact
Stock symbol
CTNM
Transactions as of
Apr 4, 2024
Transactions value $
$0
Form type
3
Date filed
4/4/2024, 05:58 PM
Previous filing
May 25, 2023
Next filing
May 23, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CTNM Stock Option (right to buy) Apr 4, 2024 Class A Common Stock 26.8K $1.01 By the Williams/Lyons-Williams Living Trust, dated May 20, 2015 F1
holding CTNM Stock Option (right to buy) Apr 4, 2024 Class A Common Stock 2.68K $8.45 By the Williams/Lyons-Williams Living Trust, dated May 20, 2015 F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options granted under the Issuer's 2012 Equity Incentive Plan. The option is fully vested.

Remarks:

Exhibit 24 - Power of Attorney